ReviewJournal of experimental & clinical cancer research : CR2025

Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?

Daisy Bhatia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.